General Information
Version
7.0
Revision date
2024-09-30
Product name
BSA+TMCS
REACH No
This
1.2.2. Uses advised against
For R&D use only. Not for pharmaceutical, household or other uses
Emergency telephone
+44 (0)870 8200418
Icons in SDS
Company Information
company name
Merck Life Science UK Limited
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H302, H314
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Flammable liquids, (Category 2) H225: Highly flammable liquid and vapor. Acute toxicity, (Category 4) H302: Harmful if swallowed. Skin corrosion, (Category 1A) H314: Causes severe skin burns and eye damage.
Signal word
Danger
Hazard statements
H225 Highly flammable liquid and vapor. H302 Harmful if swallowed. H314 Causes severe skin burns and eye damage.
Precautionary statements
P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P233 Keep container tightly closed. P264 Wash skin thoroughly after handling. P303 + P361 + P353 IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water/ shower. P370 + P378 In case of fire: Use dry sand, dry chemical or alcohol-resistant foam to extinguish. P403 + P235 Store in a well-ventilated place. Keep cool.
Supplemental label elements
EUH014 Reacts violently with water.
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
